These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6786321)

  • 21. Interactions of purified rat factor VIII/von Willebrand factor with rat and human platelets--effect of albumin and ristocetin.
    Dejana E; Furlan M; Barbieri B; Donati MB; Beck EA
    Thromb Haemost; 1984 Aug; 52(1):57-9. PubMed ID: 6437011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphological alterations of blood platelets induced by platelet activating factor (PAF) and partial inhibition by ketoprofen in calves.
    Bastos da Silva M; Dessy C; David JL; Lekeux P
    Vet Res; 1997; 28(5):489-502. PubMed ID: 9342825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet plasma membrane is equally distributed between surface and osmotically-evaginable surface-connecting membrane, independent of size, subpopulation or species.
    Frojmovic MM; Wong T; White JG
    Nouv Rev Fr Hematol (1978); 1992; 34(1):99-110. PubMed ID: 1523104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelets, von Willebrand factor, and prostaglandin I2.
    Moake JL; Tang SS; Olson JD; Troll JH; Cimo PL; Davies PJ
    Am J Physiol; 1981 Jul; 241(1):H54-9. PubMed ID: 6787937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding of thrombin-activated human factor VIII to platelets.
    Soberano ME; Clarke D; Zucker MB
    Br J Haematol; 1986 Nov; 64(3):571-85. PubMed ID: 3098274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of [3H]platelet activating factor (PAF) binding by Zn2+: a possible explanation for its specific PAF antiaggregating effects in human platelets.
    Nunez D; Kumar R; Hanahan DJ
    Arch Biochem Biophys; 1989 Aug; 272(2):466-75. PubMed ID: 2502069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents.
    Chignard M; Le Couedic JP; Vargaftig BB; Benveniste J
    Br J Haematol; 1980 Nov; 46(3):455-64. PubMed ID: 6778498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evans blue: a specific inhibitor of factor VIII-induced platelet agglutination.
    Kirby EP
    Thromb Diath Haemorrh; 1975 Dec; 34(3):770-9. PubMed ID: 1239827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet-binding of the von Willebrand factor.
    Green D; Muller HP
    Thromb Haemost; 1978 Jun; 39(3):689-94. PubMed ID: 309191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective destruction of the platelet aggregation component in bovine factor VIII preparations by reduction.
    Brown JE; Baugh R; Hougie C
    Thromb Res; 1976 Jun; 8(6):777-83. PubMed ID: 960053
    [No Abstract]   [Full Text] [Related]  

  • 31. Competitive inhibition of tritium-labeled platelet-activating factor binding to rabbit platelet membranes by amiloride and amiloride analogs.
    Hwang SB
    Biochem Biophys Res Commun; 1989 Aug; 163(1):165-71. PubMed ID: 2549986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on the mechanism of ristocetin-induced platelet aggregation: binding of factor VIII to platelets.
    Schneider-Trip MD; Jenkins CS; Kahlé LH; Sturk A; ten Cate JW
    Br J Haematol; 1979 Sep; 43(1):99-112. PubMed ID: 508625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelets fixed with paraformaldehyde: a new reagent for assay of von Willebrand factor and platelet aggregating factor.
    Allain JP; Cooper HA; Wagner RH; Brinkhous KM
    J Lab Clin Med; 1975 Feb; 85(2):318-28. PubMed ID: 234499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The binding of rabbit basophil-derived platelet-activating factor to rabbit platelets.
    Shaw JO; Henson PM
    Am J Pathol; 1980 Mar; 98(3):791-810. PubMed ID: 6987890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The platelet: membrane and surface reactions.
    Cooper HA; Mason RG; Brinkhous KM
    Annu Rev Physiol; 1976; 38():501-35. PubMed ID: 56915
    [No Abstract]   [Full Text] [Related]  

  • 36. The influence of thrombin on the platelet-aggregating activity of human factor VIII. A study with insolubilized thrombin.
    Vukovich T; Koller E; Doleschel W
    Thromb Haemost; 1979 Oct; 42(3):832-7. PubMed ID: 505400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions among bovine and human factor VIII, ristocetin, and DL-polylysine in the induction of guinea pig platelet aggregation.
    Kuwahara SS; Malik M
    Physiol Chem Phys; 1979; 11(4):337-44. PubMed ID: 538097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Properties of human asialo-factor VIII. A ristocetin-independent platelet-aggregating agent.
    De Marco L; Shapiro SS
    J Clin Invest; 1981 Aug; 68(2):321-8. PubMed ID: 6790574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity.
    Grigoriadis G; Stewart AG
    Br J Pharmacol; 1991 Sep; 104(1):171-7. PubMed ID: 1664761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet receptors for human Factor VIII/von Willebrand protein: functional correlation of receptor occupancy and ristocetin-induced platelet aggregation.
    Kao KJ; Pizzo SV; McKee PA
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5317-20. PubMed ID: 315561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.